• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Curevac N.V. (NQ: CVAC )

    2.980 -0.150 (-4.80%)
    Streaming Delayed Price Updated: 11:12 AM EDT, Jul 9, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 709,014
    Open 3.140
    Bid (Size) 2.970 (8)
    Ask (Size) 2.980 (2)
    Prev. Close 3.130
    Today's Range 2.950 - 3.150
    52wk Range 2.215 - 10.70
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Southwest Airlines Adopts a Poison Pill Plan: 7 Things to Know
    Southwest Airlines is in the news Wednesday after the airline company adopted a poison pill to battle activist investor Elliott Management. 
    Via InvestorPlace
    Why Is DouYu (DOYU) Stock Up 44% Today?
    DouYu stock is up on Wednesday after the company announced a special cash dividend for DOYU investors payable in August. 
    Via InvestorPlace

    Performance

    YTD
    -28.88%
    -28.88%
    1 Month
    -35.08%
    -35.08%
    3 Month
    -2.93%
    -2.93%
    6 Month
    -29.72%
    -29.72%
    1 Year
    -71.04%
    -71.04%

    More News

    Read More
    CureVac Layoffs 2024: What to Know About the Latest CVAC Job Cuts
    Via InvestorPlace
    Topics Workforce
    Exposures Layoff
    GOEV Stock: Canoo Receives Fleet Order From Go2 Delivery
    Via InvestorPlace
    DM Stock Alert: Nano Dimension Is Scooping Up Desktop Metal for $183 Million
    Via InvestorPlace
    GSK and CureVac to Restructure Collaboration into New Licensing Agreement
    Via ACCESSWIRE
    CureVac Announces Financial Results for the First Quarter of 2024 and Provides Business Update
    Via ACCESSWIRE
    CVAC Stock Alert: CureVac Pops on Licensing Deal With GSK
    Via InvestorPlace
    GSK Buys Full Rights To Investigational Covid-19 And Influenza Vaccines From CureVac For Around $1.5B
    Via Benzinga
    Exposures COVID-19
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Via InvestorPlace
    CureVac Initiates Strategic Restructuring to Align Resources with Focus on High-Value mRNA Pipeline Opportunities
    Via ACCESSWIRE
    CureVac Announces Voting Results of General Meeting
    Via ACCESSWIRE
    Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    First Human Death From Bird Flu Strain Puts Vaccine Stocks Back On The Map
    Via Benzinga
    Ollie's Bargain Outlet Posts Upbeat Earnings, Joins Verint Systems, Guidewire Software And Other Big Stocks Moving Higher On Wednesday
    Via Benzinga
    Why Lands' End Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    CureVac Announces Dosing of First Participant in a Phase 2 Study in Seasonal Influenza; Development in Collaboration with GSK
    Via ACCESSWIRE
    Analog Devices Posts Strong Earnings, Joins TJX, Williams-Sonoma And Other Big Stocks Moving Higher On Wednesday
    Via Benzinga
    Why XP Shares Are Trading Lower By Around 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Despegar.com Posts Strong Sales, Joins Reddit, Robinhood And Other Big Stocks Moving Higher On Friday
    Via Benzinga
    CVAC Stock Earnings: CureVac Misses EPS, Misses Revenue for Q4 2023
    Via InvestorPlace
    3 Stocks to Purge ASAP Before They’re Pulled off Life Support
    Via InvestorPlace
    Elon Musk Breaks Ranks With GOP By Praising Genetic Engineering Tech That Helped Fight COVID-19: 'Digital Medicine With Incredible Potential'
    Via Benzinga
    Spirit Airlines Posts Weak Results, Joins Integra LifeSciences, Bowlero And Other Big Stocks Moving Lower On Monday
    Via Benzinga
    COVID-19 Patent Dispute Sorted: Acuitas Therapeutics and CureVac Reach Settlement In Patent Battle
    Via Benzinga
    Topics Intellectual Property Lawsuit
    Exposures COVID-19 Financial Intellectual Property
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.